57894-0515
Rybrevant Faspro
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
INJECTION
Subcutaneous
AMIVANTAMAB
2400.0
mg/15mL
HYALURONIDASE (HUMAN RECOMBINANT)
30000.0
mg/15mL
57894-0515-01
1 VIAL, SINGLE-DOSE in 1 CARTON (57894-515-01) / 15 mL in 1 VIAL, SINGLE-DOSE
Feb. 13, 2026
Immunotherapy
Bispecific Antibody
EGFR, MET
In Use
Home